首页> 美国卫生研究院文献>World Journal of Transplantation >Treatment with plasmapheresis immunoglobulins and rituximab for chronic-active antibody-mediated rejection in kidney transplantation: Clinical immunological and pathological results

【2h】

Treatment with plasmapheresis immunoglobulins and rituximab for chronic-active antibody-mediated rejection in kidney transplantation: Clinical immunological and pathological results

机译：血浆置换免疫球蛋白和利妥昔单抗治疗在肾脏移植中用于慢性活性抗体介导的排斥反应的临床免疫学和病理学结果

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

摘要
著录项
相似文献
相关主题

摘要

AIMTo evaluate the role of a therapeutic regimen with plasma exchange, intravenous immunoglobulins and rituximab in chronic-active antibody-mediated rejection (cAMR) settings.

机译：目的评估血浆置换，静脉内免疫球蛋白和利妥昔单抗治疗方案在慢性主动抗体介导排斥（cAMR）方面的作用。

著录项

期刊名称 World Journal of Transplantation
作者
Alberto Mella; Ester Gallo; Maria Messina; Cristiana Caorsi; Antonio Amoroso; Paolo Gontero; Aldo Verri; Francesca Maletta; Antonella Barreca; Fabrizio Fop; Luigi Biancone;
展开▼
作者单位

展开▼
年(卷),期 2018(8),5
年度 2018
页码 178–187
总页数 11
原文格式 PDF
正文语种
中图分类移植;
关键词
Chronic-active antibody-mediated rejection Kidney transplantation Donor-specific antibody Rituximab;

机译：慢性活性抗体介导的排斥反应;肾脏移植;供体特异性抗体;利妥昔单抗;
入库时间 2022-08-17 12:56:10

相似文献

外文文献
中文文献
专利

1. Indicators of Treatment Responsiveness to Rituximab and Plasmapheresis in Antibody-Mediated Rejection After Kidney Transplantation (vol 99, pg 56, 2015) [J] . Immenschuh Transplantation: Official Journal of the Transplantation Society . 2016,第3期

机译：肾移植后抗体介导的排斥反应对利妥昔单抗和血浆置换的治疗反应性指标（第99卷，第56页，2015年）
2. Indicators of Treatment Responsiveness to Rituximab and Plasmapheresis in Antibody-Mediated Rejection After Kidney Transplantation [J] . Immenschuh Stephan, Zilian Eva, Daemmrich Max E., Transplantation: Official Journal of the Transplantation Society . 2015,第1期

机译：肾移植后抗体介导的排斥反应对利妥昔单抗和血浆置换的治疗反应指标
3. Intensive Plasmapheresis and Intravenous Immunoglobulin for Treatment of Antibody-Mediated Rejection After Kidney Transplant [J] . Prajej Ruangkanchanasetr, Bancha Satirapoj, SumethTermmathurapoj, Experimental and clinical transplantation . 2014,第4期

机译：强化血浆置换和静脉免疫球蛋白治疗肾移植后抗体介导的排斥反应
4. Newly developed preconditioning regimen consisting of rituximab, splenectomy and plasmapheresis for non-responders to conventional regimen in ABO-incompatible kidney transplantation [C] . Satoshi Teraoka, Koutaro Kai, Kazuhiro Iwato, Nihon Ishoku Gakkai . 2006

机译：新开发的预处理方案，由rituximab，脾切除术和血浆的非响应者对常规方案组成，在Abo-Indompative肾移植中
5. Circulating B Cells with Memory and Antibody-Secreting Phenotypes Are Detectable in Pediatric Kidney Transplant Recipients Before the Development of Antibody-Mediated Rejection [D] . Fischman, Clara. 2019

机译：在发育抗体介导的排斥之前，在儿科肾移植受者中可检测到具有记忆和抗体分泌表型的循环B细胞
6. Comparing Plasmapheresis plus IVIg with Plasmapheresis plus IVIg plus Rituximab on the Management of Suspicious Antibody-Mediated Acute Rejection in Kidney Transplant Recipients [O] . F. Ahmadi, S. Dashti-Khavidaki, M. R. Khatami, 2019

机译：比较血浆置换加血浆IVIg与血浆置换加IVIg加利妥昔单抗对可疑抗体介导的肾脏移植急性排斥反应的治疗
7. Treatment with plasmapheresis, immunoglobulins and rituximab for chronic-active antibody-mediated rejection in kidney transplantation: Clinical, immunological and pathological results [O] . Alberto Mella, Ester Gallo, Maria Messina, 2018

机译：用浆术治疗，免疫球蛋白和RITUXIMAB用于肾移植中的慢性活性抗体介导的排斥反应：临床，免疫学和病理结果

Treatment with plasmapheresis immunoglobulins and rituximab for chronic-active antibody-mediated rejection in kidney transplantation: Clinical immunological and pathological results

摘要

著录项

相似文献

相关主题

期刊订阅